tirzepatide vs semaglutide vs ozempic for Weight Loss: Which Works Better? Tirzepatide vs. Semaglutide: Key Differences

Testing for peptide pathway predispositions can provide context about your baseline receptor sensitivity and how your body may respond to GLP-1 therapy

Semaglutide was extensively tested in several phase 3 trials for its therapeutic potential, including as part of the Semaglutide Treatment Effect in People with Obesity (STEP) and Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) clinical programs

Semaglutide (the generic name for Ozempic) and tirzepatide (the generic name for Mounjaro) are a type of drug known as a GLP-1, and they work by interacting with the hunger part of the brain and suppressing the appetite, causing patients to feel full quicker

Those with pre-existing low blood pressure or diabetes on insulin are at slightly higher risk